Advertisement
Becton Dickinson
Subscribe to Becton Dickinson

The Lead

BD to Acquire CareFusion for $12.2 Billion

October 6, 2014 9:48 am | by PR Newswire | News | Comments

BD and CareFusion have announced a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to create a global leader in medication management and patient safety solutions...

BD Launches New Point-of-Care System for HIV/AIDS Patients

April 24, 2014 9:26 am | by PR Newswire | News | Comments

BD Biosciences, a segment of BD (Becton, Dickinson and Company), a leading global medical...

Diagnosing Group A Strep in Minutes with New Test

February 25, 2014 9:36 am | by PR Newswire | News | Comments

BD Diagnostics, a segment of BD, a leading global medical technology company, announced today...

BD Acquires Alverix

January 7, 2014 2:49 pm | by PR Newswire | News | Comments

BD, a leading global medical technology company, announced today that it has acquired Alverix,...

View Sample

FREE Email Newsletter

Zimmer, Abbott, others rake in hundreds of millions in fed contracts

September 26, 2013 4:17 pm | by Mass Device | News | Comments

Federal agencies have handed out a slew of contracts and contract extensions in recent weeks, including about $370 million in deals for medical supplies and devices. The biggest takers were Becton Dickinson & Co., Johnson & Johnson, and Synthes, who together claimed more than half of the contract funding.

BD Supports the FDA's Proposal to Reclassify Rapid Influenza Tests

August 26, 2013 9:32 am | by PR Newswire | News | Comments

BD, a leading global medical technology company, supports the U.S. Food and Drug Administration's (FDA's) proposed reclassification of rapid influenza detection tests. A hearing, held on June 13th by FDA's CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA's proposal to reclassify rapid influenza detection tests (RIDTs) currently regulated as Class I devices, into Class II devices.

Becton false advertising and antitrust lawsuit heads to trial

August 22, 2013 11:29 am | by Mass Device | News | Comments

Becton Dickinson & Co. (NYSE:BDX) is headed to court next month to speak to allegations, brought by rival Retractable Technologies' (NYSE:RVP), that it engaged in illegal in order to maintain a monopoly in the syringe business.  

Advertisement

BD Diagnostics Advances Commitment to a Fully Integrated Microbiology Solution with New Agreement

April 26, 2013 2:19 pm | by Bio-Medicine.Org | News | Comments

SPARKS, Md. , April 27, 2013 /- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today an international distributor agreement with Bruker Daltonics Inc. to sell and provide front-line technical support for the co-labeled BD™ Bruker MALDI Biotyper™ System. Microbial identification and antimicrobial susceptibility testing is the end-poin...

Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.

February 21, 2013 8:01 am | by The Associated Press | News | Comments

Today, National Traders Association announced new research reports highlighting Bruker Corporation (NASDAQ: BRKR), Agilent Technologies Inc. (NYSE: A), General Electric Company (NYSE: GE), Becton, Dickinson and Co. (NYSE: BDX) and Thermo Fisher Scientific Inc. (NYSE: TMO). Today's readers...

BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care

September 19, 2012 12:06 pm | News | Comments

Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that include needle anxiety[i-iii]. Patients who reported injection-related pain or embarrassment also admitted they intentionally skipped insulin injections more often. A study by the American Association of Diabetes Educators (AADE) revealed that...

BD Veritor System for Flu A+B Featuring Alverix Technology Receives Regulatory Approval in Japan

February 9, 2012 5:02 am | News | Comments

SAN JOSE, Calif.--(BUSINESS WIRE)--Alverix announced today that BD (Becton, Dickinson and Company) has received approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for the BD Veritorâ„¢ System Flu A+B Test. The BD Veritor System was developed...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading